De mest almindeligt observerede bivirkninger relateret til anvendelsen af Tasmar, som forekommer hyppigere end hos placebobehandlede patienter fremgår af nedenstående tabel.
The most commonly observed adverse events associated with the use of Tasmar, occurring more frequently than in placebo-treated patients are listed in the table below.